Breaking news – Pagina 261 – AMD

Breaking news

Marzo 27, 2018

Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study

Herrington WG, Alegre-Díaz J, Wade R, et al.
The Lancet Diabetes & Endocrinology. Pub. online March 19, 2018.

Leggi

Marzo 27, 2018

Impact of peer support on inpatient and outpatient payments among people with Type 2 diabetes: a prospective cohort study

Yu D, Graffy J, Holman D, et al.
Diabetic Medicine. Pub. online March 25, 2018.

Leggi

Marzo 27, 2018

Diabetes duration, HbA1c, and cause-specific mortality in Mexico

Arredondo A
The Lancet Diabetes & Endocrinology. Pub. online March 19, 2018.

Leggi

Marzo 23, 2018

The Black-White Cardiovascular Health Disparity Is Narrowing, But Not for the Reason You Think

Mensah GA
Annals of Internal Medicine. Pub. online 20 March 2018.

Leggi

Marzo 23, 2018

Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark

Safai N, Carstensen B, Vestergaard H, Ridderstråle M
BMJ Open 2018;8:e019214

Leggi

Marzo 23, 2018

Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist

Bethel MA, McMurray JJV
Circulation. 2018;137:1218-20

Leggi

Marzo 23, 2018

Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014

Brown AF, Liang L-J, Vassar SD, et al.
Annals of Internal Medicine. Pub. online 20 March 2018.

Leggi

Marzo 23, 2018

Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments

Leening MJG, Ikram MA
PLoS Med. Pub. online 20 March 2018.

Leggi

Marzo 23, 2018

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data

Karmali KN, Lloyd-Jones DM, van der Leeuw J, et al.
PLoS Med. Pub. online 20 March 2018.

Leggi

Marzo 23, 2018

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

Abrahami D, Douros A, Yin H, et al.
BMJ. 2018;360:k872

Leggi